CROSARA, Serena
 Distribuzione geografica
Continente #
NA - Nord America 954
EU - Europa 867
AS - Asia 390
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.222
Nazione #
US - Stati Uniti d'America 944
CN - Cina 272
IE - Irlanda 220
IT - Italia 212
SE - Svezia 160
TR - Turchia 63
FI - Finlandia 59
AT - Austria 54
DE - Germania 48
BE - Belgio 37
FR - Francia 23
GB - Regno Unito 19
IR - Iran 19
IN - India 12
UA - Ucraina 12
SG - Singapore 10
BR - Brasile 8
HU - Ungheria 6
TW - Taiwan 6
JP - Giappone 5
NL - Olanda 5
CA - Canada 4
MX - Messico 4
CH - Svizzera 3
EE - Estonia 2
HN - Honduras 2
NO - Norvegia 2
QA - Qatar 2
A1 - Anonimo 1
CZ - Repubblica Ceca 1
EU - Europa 1
HR - Croazia 1
IL - Israele 1
MK - Macedonia 1
PE - Perù 1
RO - Romania 1
RU - Federazione Russa 1
Totale 2.222
Città #
Dublin 220
Chandler 210
Ann Arbor 110
Ashburn 101
Beijing 71
Izmir 61
Dearborn 58
Nanjing 45
Vienna 42
Parma 39
Princeton 37
Brussels 36
Wilmington 27
Shanghai 24
Bremen 21
Shenyang 20
Kunming 14
Boardman 13
Hebei 13
Sant'ilario D'enza 12
Fremont 11
Mountain View 11
San Mateo 11
Jacksonville 10
London 10
Woodbridge 10
Changsha 9
Jinan 9
Milan 9
Nanchang 9
Zanjan 9
Helsinki 8
New York 8
Jiaxing 7
São Paulo 7
Brescia 6
Chicago 6
Des Moines 6
Hefei 6
Ningbo 6
Pignone 6
Vicopisano 6
Washington 6
Abano Terme 5
Bougligny 5
Genoa 5
Los Angeles 5
Monza 5
Preston City 5
Seattle 5
Zhengzhou 5
Chengdu 4
Düsseldorf 4
Falls Church 4
Guangzhou 4
Hangzhou 4
Sassuolo 4
Verona 4
Bari 3
Chieti 3
Haikou 3
Leawood 3
Magenta 3
Mexico City 3
Mumbai 3
New Taipei 3
Norwalk 3
Pune 3
Sacramento 3
San Lazzaro di Savena 3
Tianjin 3
Tokyo 3
Vaiano Cremasco 3
Wake Forest 3
Berlin 2
Bologna 2
Borås 2
Casanova Lonati 2
Catania 2
Doha 2
Fairfield 2
Frankfurt am Main 2
Fuzhou 2
Giessen 2
Hanover 2
Houston 2
Lodi 2
Montreal 2
Nonantola 2
Oslo 2
Paderno Dugnano 2
Padova 2
Palermo 2
Pingtung City 2
Redwood City 2
Reggio Emilia 2
Reggio Nell'emilia 2
Rocklin 2
Rockville 2
Solaro 2
Totale 1.528
Nome #
Efficacy of imidacloprid 10%/moxidectin 2.5% spot on (Advocate®, Advantage Multi®) and doxycycline for the treatment of natural Dirofilaria immitis infections in dogs 156
Normal aortic annulus dimensions in Boxer dogs according to sex and body weight 133
Aorto-septal angle, isolated basal septal hypertrophy and systolic murmurs in 122 cats 114
Transthoracic echocardiography in clinically healthy adult Newfoundland dogs: reference values for the breed 103
Systolic Arterial Pressure Measured Simultaneously by Doppler Technique, Using Forelimb and Hindlimb in Dogs 88
Tetralogia di Fallot in un gatto 87
Aorto-septal angle and systolic murmur in apparently healthy cats: a pilot study 84
Migration of a Kirschner wire to the heart in a Yorkshire terrier 67
DELay of Appearance of sYmptoms of Canine Degenerative Mitral Valve Disease Treated with Spironolactone and Benazepril: the DELAY Study 67
ECG of the month 64
Wolbachia, doxycycline and macrocyclic lactones: New prospects in the treatment of canine heartworm disease 59
Effect of sampling time on urinary electrolytes following oral furosemide administration in dogs with myxomatous mitral valve disease 59
Anatomic distribution and electrophysiologic properties of accessory atrioventricular pathways in dogs 56
The predictive value of clinical, radiographic, echocardiographic variables and cardiac biomarkers for assessing risk of the onset of heart failure or cardiac death in dogs with preclinical myxomatous mitral valve disease enrolled in the DELAY study 56
Evaluation of plasma activity of matrix metalloproteinase-2 and -9 in dogs with myxomatous mitral valve disease 54
Screening for subaortic stenosis in Boxers in Italy 51
Corner Diagnostico di Cardiologia 51
Endocardite batterica 50
Holter monitoring in 36 dogs with myxomatous mitral valve disease 48
Miocardiopatie del cane 48
La malattia valvolare mitralica nel cane 47
Diagnostic performance of P wave duration in the identification of left atrial enlargement in dogs 47
Effects of pimobendan on myocardial perfusion and pulmonary transit time in dogs with myxomatous mitral valve disease: a pilot study. 46
Insufficienza cardiaca: fisiopatologia e principi di terapia 44
Systolic arterial pressure measured simultaneously by Doppler technique, using forelimb and hindlimb, in dogs 44
Malattia cronica mitralica 43
Effects of pimobendan on myocardial perfusion and pulmonary transit time in dogs with myxomatous mitral valve disease: a pilot study. 43
Radiofrequency catheter ablation of concealed accessory pathways in two dogs with symptomatic atrioventricular reciprocating tachycardia 42
Prevalence and Prognostic Importance of Pulmonary Hypertension in Dogs with Myxomatous Mitral Valve Disease 39
The longitudinal outcome of canine (K9) myxomatous mitral valve disease (LOOK-Mitral) registry: Baseline treatment characteristics 39
Survival Characteristics and Prognostic Variables of Dogs with Preclinical Chronic Degenerative Mitral Valve Disease Attributable to Myxomatous Degeneration 38
Predictors of reoccurrence of congestive signs within 180 days after successful treatment of the first episode of congestive heart failure in dogs with myxomatous mitral valve disease 38
The Longitudinal Outcome Of Canine (K9) myxomatous mitral valve disease (LOOK-Mitral registry): Baseline characteristics 37
Use of contrast echocardiography for quantitative and qualitative evaluation of myocardial perfusion and pulmonary transit time in healthy dogs 35
Preliminary investigation of cardiovascular-renal disorders in dogs with chronic mitral valve disease 35
Utility of 12-Lead Electrocardiogram for Differentiating Paroxysmal Supraventricular Tachycardias in Dogs 34
Holter monitoring in dogs with mitral regurgitation and different class of heart failure 33
Survival Characteristics and Prognostic Variables of Dogs with Mitral Regurgitation Attributable to Myxomatous Valve Disease 32
Natural history and risk predictors of chronic degenerative mitral valve disease in asymptomatic dogs 28
Evaluation of urinary neutrophil gelatinase‐associated lipocalin to detect renal tubular damage in dogs with stable myxomatous mitral valve disease 27
Aorto-septal angle, isolated basal septal hypertrophy, and systolic murmur in 122 cats 12
Predictors of reoccurrence of congestive signs within 180 days after successful treatment of the first episode of congestive heart failure in dogs with myxomatous mitral valve disease 8
Suspected Drinking Water Poisoning in a Domestic Kitten with Methemoglobinemia 8
Association between echocardiographic indexes and urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL) in dogs with myxomatous mitral valve disease 3
Effect of the sampling time on urinary electrolytes following furosemide administration in dogs with myxomatous mitral valve disease 2
Wolbachia, doxycycline and macrocyclic lactones: New prospects in the treatment of canine heartworm disease 1
Totale 2.300
Categoria #
all - tutte 7.549
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.549


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201984 0 0 0 0 0 0 0 0 4 4 69 7
2019/2020403 78 75 17 9 17 57 36 24 19 59 8 4
2020/2021145 3 8 12 5 23 13 4 15 32 17 7 6
2021/2022242 34 5 6 14 13 5 7 26 10 15 33 74
2022/2023903 69 85 63 68 71 91 19 68 289 25 29 26
2023/2024345 32 40 28 22 36 98 24 43 22 0 0 0
Totale 2.300